SEC Form 4 · accession 0001209191-18-056978
MARRONE BIO INNOVATIONS INC · MBII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela G Marrone
Officer — CEO · Director
Period of report
Oct 31, 2018
Accepted (ET)
Nov 2, 2018 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001441693
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 31, 2018 | M | 9,559 | $1.1926 | A | 817,675 | D | |
| Common Stock | holding | — | — | — | 53,134 | I | Jointly with Spouse | |
| Common StockF1 | holding | — | — | — | 6,442 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F2 | $1.1926 | Oct 31, 2018 | M | 9,559 | D | — | Jan 28, 2019 | Common Stock | 9,559 | 0 | D |
Explanation of responses
- F1Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
- F2The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of January 1, 2009, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.